# Salient Surgical Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/salient-surgical-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Portsmouth, US
- Website: www.salientsurgical.com
- Total disclosed funding: $121M
- Latest round: Series G (Jan 6, 2010)
- Investors on record: 20

## About

Established in 1999, Salient Surgical Technologies, Inc. is a global, privately held medical technology company that develops and markets advanced energy devices used in surgical procedures.

## Funding rounds

- Series G, Jan 6, 2010, $15M — Affinity Capital Management, Certain tonometry assets of Medtronic Inc., Arnerich Massena & Associates, Apothecary Capital
- Series F, Sep 30, 2008, $18M — RiverVest Ventures Partners, Certain tonometry assets of Medtronic Inc., Piper Sandler, Arnerich Massena & Associates
- Series E, Jun 5, 2007, $20M — RiverVest Ventures Partners, Arnerich Massena & Associates
- Series D, Feb 13, 2003, $30M — Vanguard Ventures, Crown Advisors International, Brait Private Equity, RiverVest Ventures Partners, Questmark Management Company, Rahn Group, MB Venture Partners, Arnerich Massena & Associates, Synergy Ventures, Frantz Medical Ventures, Merlin BioMed Group, Medtronic plc
- Series C, Apr 1, 2002, $15M — Vanguard Ventures, Crown Advisors International, Brait Private Equity, RiverVest Ventures Partners, Rahn Group, Medtronic, Legacy Hospital Partners Inc., Arnerich Massena & Associates, Synergy Ventures, Frantz Medical Ventures
- Series B, Oct 20, 2000, $20M — Crescendo Ventures, Vanguard Ventures, Crown Advisors International, Brait Private Equity, RiverVest Ventures Partners, Columbia Threadneedle Investments, Rahn Group, Synergy Ventures, Medtronic plc
- Seed, Aug 1, 1999, $4M — Crescendo Ventures, Vanguard Ventures, Medtronic plc

## Investors

- Crescendo Ventures (https://capitalatlas.ai/funds/crescendo-ventures) — Seed, Series B
- Vanguard Ventures (https://capitalatlas.ai/funds/vanguard-ventures) — Seed, Series B, Series C, Series D
- Medtronic plc — Seed, Series B, Series D
- Crown Advisors International (https://capitalatlas.ai/funds/crown-advisors-international) — Series B, Series C, Series D
- Brait Private Equity (https://capitalatlas.ai/funds/brait-private-equity) — Series B, Series C, Series D
- RiverVest Ventures Partners (https://capitalatlas.ai/funds/rivervest-ventures-partners) — Series B, Series C, Series D, Series E, Series F
- Columbia Threadneedle Investments — Series B
- Rahn Group (https://capitalatlas.ai/funds/rahn-group) — Series B, Series C, Series D
- Synergy Ventures (https://capitalatlas.ai/funds/synergy-ventures) — Series B, Series C, Series D
- Medtronic — Series C
- Legacy Hospital Partners Inc. — Series C
- Arnerich Massena & Associates — Series C, Series D, Series E, Series F, Series G
- Frantz Medical Ventures (https://capitalatlas.ai/funds/frantz-medical-ventures) — Series C, Series D
- Questmark Management Company (https://capitalatlas.ai/funds/questmark-management-company) — Series D
- MB Venture Partners (https://capitalatlas.ai/funds/mb-venture-partners) — Series D
- Merlin BioMed Group — Series D
- Certain tonometry assets of Medtronic Inc. — Series F, Series G
- Piper Sandler (https://capitalatlas.ai/funds/piper-sandler) — Series F
- Affinity Capital Management (https://capitalatlas.ai/funds/affinity-capital-management) — Series G
- Apothecary Capital — Series G